Clinical Trials on CYP2C19 Genetic Variants in United Kingdom
Total 7796 results
-
Stanford UniversityRecruiting
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
Genelex CorporationHarding UniversityCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme... and other conditionsUnited States
-
Genelex CorporationCompletedDrug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome P450 CYP2C9 Enzyme Deficiency | Cytochrome P450 CYP2C19 Enzyme Deficiency | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | CYP2D6 Polymorphism | Ultrarapid... and other conditionsUnited States
-
National Human Genome Research Institute (NHGRI)Enrolling by invitation
-
Great Ormond Street Hospital for Children NHS Foundation...WithdrawnGranulomatous Disease, Chronic, X-linked, VariantUnited Kingdom
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
University of CambridgeSanofiRecruiting
-
Cleveland Medical Devices IncNational Institute of Neurological Disorders and Stroke (NINDS)CompletedELECTROENCEPHALOGRAPHIC VARIANT PATTERN 1 (Disorder)United States
-
The Leeds Teaching Hospitals NHS TrustGenomic Medicine Services AllianceCompletedGenetic Disease | Bereavement | Fetal AnomalyUnited Kingdom
-
Stanford UniversityAstraZenecaTerminatedBladder Adenocarcinoma | Bladder Mixed Adenocarcinoma | Bladder Squamous Cell Carcinoma | Infiltrating Bladder Urothelial Carcinoma With Giant Cells | Infiltrating Bladder Urothelial Carcinoma, Nested Variant | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Bladder Urothelial... and other conditionsUnited States
-
NHS National Waiting Times Centre BoardBritish Heart Foundation; University of Glasgow; NHS Greater Clyde and Glasgow; Chief Scientist Office of the Scottish GovernmentActive, not recruitingAngina, Stable | Angina Pectoris, Variant | Microvascular AnginaUnited Kingdom
-
National Human Genome Research Institute (NHGRI)CompletedGenetics | Birth Defects | Genetic Disease | Genetic Linkage | Genetic VariationUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingSickle Cell | PKLR Variants | Adenosine Triphosphate ActivitiesUnited States
-
Oxford Brookes UniversitySt. Mary's University, TwickenhamCompletedFood Preferences | Genetic Predisposition | PsychologicalUnited Kingdom
-
University of LeicesterActive, not recruitingGenetic Disease | Screening | Aortic Aneurysm and DissectionUnited Kingdom
-
Idorsia Pharmaceuticals Ltd.CompletedGM2 Gangliosidosis | GM1 Gangliosidosis | Tay-Sachs Disease | Sandhoff Disease | Gaucher Disease, Type 2 | AB Variant Gangliosidosis GM2United States, Spain, Germany, Italy, Belgium, Brazil, France, Portugal, Switzerland, United Kingdom
-
Mayo ClinicNot yet recruitingSide Effect of Drug | Pharmacogenomic Drug Interaction | Drug Metabolism, Poor, CYP2D6-Related | Ineffective Drug Action | Drug Metabolism, Poor, CYP2C19-RelatedUnited States
-
Sangamo TherapeuticsEnrolling by invitationFabry Disease | Fabry Disease, Cardiac VariantUnited States, Australia, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant | Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation | Infiltrating Bladder Urothelial Carcinoma With Squamous... and other conditionsUnited States
-
University of OxfordUniversity College, London; Moorfields Eye Hospital NHS Foundation TrustCompleted
-
Nottingham University Hospitals NHS TrustKing's College Hospital NHS Trust; The Leeds Teaching Hospitals NHS Trust; Manchester... and other collaboratorsRecruitingRespiratory Tract Diseases | Lung Diseases | Cystic Fibrosis | Genetic Disease | Digestive System Disease | Pancreatic DiseaseUnited Kingdom
-
Atopix Therapeutics, Ltd.Completed
-
BenevolentAI BioCompletedAtopic DermatitisUnited Kingdom
-
King's College LondonUniversity of Nottingham; Imperial College London; University of Sheffield; Guy... and other collaboratorsUnknown
-
Aerovance, Inc.CompletedAtopic EczemaUnited Kingdom
-
University of DundeeNHS TaysideCompletedAtopic EczemaUnited Kingdom
-
University College, LondonDermatrustWithdrawn
-
GlaxoSmithKlineCompleted
-
University of UlsterCompletedBlood PressureUnited Kingdom
-
Imperial College LondonJP Moulton Charitable FoundationRecruitingAtopic Dermatitis EczemaUnited Kingdom
-
ACO Hud Nordic ABThe University of Sheffield Medical SchoolCompletedDermatitis, AtopicUnited Kingdom
-
Momentum DataPfizer; Royal College of General Practitioners Research and Surveillance CentreUnknownEczema | Atopic Dermatitis | Atopic Dermatitis EczemaUnited Kingdom
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; National Institute for Health Research, United KingdomCompletedChild | Atopic Dermatitis | Atopic EczemaUnited Kingdom
-
LEO PharmaCompleted
-
St Mary's University CollegeFulham Football ClubCompletedInjuries | Genetic ChangeUnited Kingdom
-
AnaMar ABCovanceCompletedAtopic DermatitisUnited Kingdom
-
Imperial College LondonSarepta Therapeutics, Inc.; Department of Health, United KingdomCompletedDuchenne Muscular DystrophyUnited Kingdom
-
University of AberdeenRecruitingTakotsubo CardiomyopathyUnited Kingdom
-
University of VirginiaAmerican Heart AssociationRecruitingIschemic Stroke | CYP2C19 PolymorphismUnited States
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; Cardiff University; University of SurreyCompleted
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; University of Oxford; Queen Mary University... and other collaboratorsRecruitingProstate Cancer | Genetic Counselling | Genetic Markers | Prostate BiopsyUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | Pleomorphic Variant Mantle Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | Pleomorphic Variant Mantle Cell LymphomaUnited States
-
Novo Nordisk A/SCompleted
-
Great Ormond Street Hospital for Children NHS Foundation...Unknown
-
LEO PharmaCompletedAtopic DermatitisUnited Kingdom
-
Ziarco Pharma LtdCompletedAtopic DermatitisUnited Kingdom
-
St Mary's University CollegeFulham Football ClubCompletedTendon Injuries | Apophysitis | Genetic Predisposition | Ligament Injury | Muscle Strain | Fractures in ChildrenUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldActive, not recruiting